Updated: 48 min 21 sec ago
Sun, 11/23/2008 - 7:00pm
ScienceDaily (Nov. 21, 2008) Scientists at the University of Texas at Austin have identified pathways by which a reduced-calorie diet and exercise can modify a postmenopausal woman's risk of breast cancer.
Sun, 11/23/2008 - 7:00pm
NEW YORK (Reuters Health) - In people with type 1 diabetes, adequate control of blood sugar over the long haul helps reduce the risk of diabetes-related eye and kidney disease, new data suggest.
Thu, 11/20/2008 - 7:00pm
Nov. 21 (Bloomberg) -- The global economic crisis has cut funding for biotechnology companies to the lowest level in a decade, triggering bankruptcies and threatening development of drugs based on biomedical breakthroughs.
Thu, 11/20/2008 - 7:00pm
SEATTLE, Nov. 21 /PRNewswire/ -- Attorneys representing consumers and third-party payers today announced a proposed landmark $350 million settlement with healthcare services giant McKesson to settle allegations the company fraudulently inflated the price of more than 400 prescription drugs by manipulating drug-pricing benchmarks.
(Logo: http://www.newscom.com/cgi-bin/prnh/200803...
Thu, 11/20/2008 - 7:00pm
ORCHARD PARK, N.Y., Nov. 20 /PRNewswire-FirstCall/ -- MINRAD International, Inc. , announced effective today it will reduce its workforce by approximately 35% or 50 positions.
Dave DiGiacinto, President and Chief Operating Officer, said, "We have taken this difficult, but necessary action to reduce our cost structure to conserve our cash in response to our current adverse financial...
Thu, 11/20/2008 - 7:00pm
CAMBRIDGE, Mass.--(BUSINESS WIRE)--CombinatoRx, Incorporated (NASDAQ: CRXX) today announced a further restructuring, effective immediately, to focus on the core strength of the company: identifying novel product candidates based on unexpected biological synergies. This restructuring will include a planned further reduction of the Companys Cambridge workforce by approximately 30 employees, bringing...
Thu, 11/20/2008 - 7:00pm
DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced the closing of the second and final tranche of a $35.2 million Series C financing from a top-tier, international syndicate of new and existing investors. The first tranche was completed in April 2008.
Argos has made substantial progress in all areas of focus since the closing of the first tranche of this financing, triggering...
Thu, 11/20/2008 - 7:00pm
SAN DIEGO, Nov. 21 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL - News) today announced a strategic restructuring including a staff reduction of 29 employees, approximately 20% of the company's total workforce, and accelerated closure of a research facility. Following the restructuring, the company will have approximately 120 employees and expects to reduce future net losses and cash...
Thu, 11/20/2008 - 7:00pm
CHICAGO, Nov. 20 (UPI) -- Doctors have tricked mouse immune systems into "thinking" cells from a donor pancreas are theirs, bringing hope to diabetes patients, U.S. researchers said.
Thu, 11/20/2008 - 7:00pm
ScienceDaily (Nov. 21, 2008) The DNA in our cells is constantly under assault from oxygen, the sun's radiation and environmental stresses. Most of the time, our cells can repair the damage before it gets copied into a permanent mutation that could lead to cancer.
Thu, 11/20/2008 - 7:00pm
CHARLOTTESVILLE, Va., Nov. 20 -- Variation in the gene for the serotonin transporter appears to be linked to how much some alcoholics drink, researchers here said.
Thu, 11/20/2008 - 7:00pm
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND - News) announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of GlaxoSmithKlines (GSK) PROMACTA (eltrombopag) for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids...
Thu, 11/20/2008 - 7:00pm
ScienceDaily (Nov. 20, 2008) A team of researchers at Duke University Medical Center and the Universit catholique de Louvain (UCL) has found that lactic acid is an important energy source for tumor cells. In further experiments, they discovered a new way to destroy the most hard-to-kill, dangerous tumor cells by preventing them from delivering lactic acid.
Thu, 11/20/2008 - 7:00pm
ScienceDaily (Nov. 20, 2008) Dalhousie Medical School researchers have discovered that embryonic stem cells may play a critical role in helping people with nerve damage and motor neuron diseases, such as amyotrophic lateral sclerosis (ALS), regain muscular strength.
Thu, 11/20/2008 - 7:00pm
THURSDAY, Nov. 20 (HealthDay News) -- Higher levels of estrogen during ovulation may explain why women with cystic fibrosis tend to fare worse than men with the respiratory disease, researchers at the University of North Carolina report.
Thu, 11/20/2008 - 7:00pm
Times of India -- Vitamin D deficiency results in part from reduced exposure to sunlight, which is common during cold weather months when days are shorter and more time is spent indoors. "Chronic vitamin D deficiency may be a culprit in heart disease, high blood pressure and metabolic syndrome," said Sue Penckofer, PhD, study author and professor, Marcella Niehoff School of Nursing, Loyola University...
Thu, 11/20/2008 - 7:00pm
Nov. 20 (Bloomberg) -- A new technique could map DNA sequences 30,000 times faster than current methods, accelerating researchers' work to unravel the complex mutations that cause human disease.
Thu, 11/20/2008 - 7:00pm
WOODCLIFF LAKE, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX - News) today announced that the U.S. District Court for the District of New Jersey last night granted AstraZeneca Pharmaceuticals' motion for a temporary restraining order (TRO) halting sales of Teva's generic Pulmicort Respules (budesonide inhaled solution). In conjunction with the Court's Order...
Thu, 11/20/2008 - 7:00pm
SINGAPORE, Nov 20 (Bernama) -- A team of Singapore researchers has made a breakthrough in developing an unlimited number of pure insulin-producing cells from mouse embryonic stem cells that are highly effective in treating diabetes.
Thu, 11/20/2008 - 7:00pm
PALO ALTO, Calif., and BRUSSELS, Belgium, Nov. 20 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ - News) and UCB (Euronext Brussels: UCB) announced today positive preliminary top-line results from the first of two Phase III pivotal clinical trials of sodium oxybate (JZP-6) for the treatment of fibromyalgia. The randomized, double-blind, placebo-controlled study achieved its primary...